Multiple Myeloma Coverage from Every Angle

Adam D. Cohen, MD, on Multiple Myeloma: Findings on CART-BCMA Infusions

Posted: Monday, December 11, 2017

Adam D. Cohen, MD, of the Abramson Cancer Center, University of Pennsylvania, discusses data on the safety and efficacy of B-cell maturation antigen-specific chimeric antigen receptor T cells with cyclophosphamide conditioning for refractory multiple myeloma.

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.